Merck makes a big move into new cancer treatments with a $6.7 billion
buyout deal
-
Merck to spend $6.7 billion to buy Terns Pharmaceuticals, which is
developing an oral treatment for leukemia.
55 minutes ago







No comments:
Post a Comment